Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.013 USD | -35.00% | -13.33% | -89.47% |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
Mar. 12 | News Highlights : Top Company News of the Day - Tuesday at 5 AM ET | DJ |
Financials (USD)
Sales 2021 | 52.9M | Sales 2022 | 62.84M | Capitalization | 411M |
---|---|---|---|---|---|
Net income 2021 | -428M | Net income 2022 | -573M | EV / Sales 2021 | 29.1 x |
Net Debt 2021 | 111M | Net Debt 2022 | 84.53M | EV / Sales 2022 | 7.89 x |
P/E ratio 2021 |
-3.2
x | P/E ratio 2022 |
-0.65
x | Employees | 949 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.77% |
1 day | +25.00% | ||
1 week | +25.00% | ||
Current month | +25.00% | ||
3 months | -46.67% | ||
6 months | -69.97% | ||
Current year | -83.81% |
Managers | Title | Age | Since |
---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 59 | 88-12-31 |
Shawn Sahebi
COO | Chief Operating Officer | - | - |
Mike A. Royal
CTO | Chief Tech/Sci/R&D Officer | 70 | 14-03-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kim D. Janda
BRD | Director/Board Member | 67 | 12-03-31 |
David Lemus
BRD | Director/Board Member | 61 | 17-09-30 |
Jaisim Shah
BRD | Director/Board Member | 63 | 13-09-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.013 | -35.00% | 42 760 |
24-05-07 | 0.02 | +25.00% | 117,022 |
24-05-06 | 0.016 | +6.67% | 128,899 |
24-05-03 | 0.015 | +7.14% | 38,279 |
24-05-02 | 0.014 | -6.67% | 13,565 |
Delayed Quote OTC Markets, May 07, 2024 at 03:46 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-83.81% | 10.87M | |
+0.82% | 106B | |
+8.38% | 23.47B | |
-13.89% | 21.9B | |
-6.22% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B | |
+327.78% | 8.78B |
- Stock Market
- Equities
- SRNE Stock